Effect of synthetic prostaglandin E1 analog on aspirin-induced gastric bleeding and secretion
- PMID: 6604619
- DOI: 10.1007/BF01317040
Effect of synthetic prostaglandin E1 analog on aspirin-induced gastric bleeding and secretion
Abstract
Twelve healthy subjects were given aspirin (975 mg four times a day) for four days. On days three and four, each dose of aspirin was preceded by a synthetic protaglandin E1 analog (misoprostol, Searle) either 25 micrograms, 50 micrograms, or placebo in a double-blind balanced full crossover design. Bleeding, gastric secretion of acid and chloride, and accumulation of gastric luminal DNA and calcium as indices of cell shedding and mucus secretion were measured by three daily morning gastric washouts, corrected for gastric emptying. Both bleeding and gastric secretion were greater on day 4 with aspirin and placebo than on day 0. With 50 micrograms misoprostol, and to a lesser extent with 25 micrograms, bleeding and gastric secretion were reduced on day 4 compared to day 4 with placebo or aspirin only days. The reduction in gastric bleeding with the 50-microgram dosage of misoprostol was directly related to the reduction in acid secretion. The ratios of changes in acid and chloride outputs did not indicate any increase in bicarbonate secretion. No changes in the recoveries of calcium or DNA were seen.
Similar articles
-
Effect of prostaglandin E2 on gastric mucosal bleeding caused by aspirin.Dig Dis Sci. 1981 Apr;26(4):301-5. doi: 10.1007/BF01308369. Dig Dis Sci. 1981. PMID: 6972294 Clinical Trial.
-
Reduction of aspirin-induced fecal blood loss with low-dose misoprostol tablets in man.Dig Dis Sci. 1985 Jul;30(7):605-11. doi: 10.1007/BF01308407. Dig Dis Sci. 1985. PMID: 3924533 Clinical Trial.
-
Gastrointestinal cytoprotective effects of misoprostol. Clinical efficacy overview.Dig Dis Sci. 1985 Nov;30(11 Suppl):194S-200S. doi: 10.1007/BF01309408. Dig Dis Sci. 1985. PMID: 3932054 Clinical Trial.
-
The therapeutic efficacy of misoprostol in peptic ulcer disease.Postgrad Med J. 1988;64 Suppl 1:60-77. Postgrad Med J. 1988. PMID: 3138682 Review.
-
Gastrointestinal effects of antipyretic analgesics.Am J Med. 1983 Nov 14;75(5A):53-64. doi: 10.1016/0002-9343(83)90233-4. Am J Med. 1983. PMID: 6359868 Review.
Cited by
-
Gastric protection by misoprostol against 1300 mg of aspirin. An endoscopic study.Dig Dis Sci. 1986 Feb;31(2 Suppl):137S-141S. doi: 10.1007/BF01309339. Dig Dis Sci. 1986. PMID: 3080286 Clinical Trial.
-
Healing of benign gastric ulcer. A placebo-controlled comparison of two dosage regimens of misoprostol, a synthetic analog of prostaglandin E1.Dig Dis Sci. 1985 Nov;30(11 Suppl):164S-170S. doi: 10.1007/BF01309404. Dig Dis Sci. 1985. PMID: 3932050 Clinical Trial.
-
Double blind controlled study on the effect of sucralfate on gastric prostaglandin formation and microbleeding in normal and aspirin treated man.Gut. 1986 Dec;27(12):1450-6. doi: 10.1136/gut.27.12.1450. Gut. 1986. PMID: 3492413 Free PMC article. Clinical Trial.
-
Dose-response, meal-stimulated gastric antisecretory study of prostaglandin E1 analog, misoprostol, in man.Dig Dis Sci. 1988 Mar;33(3):298-302. doi: 10.1007/BF01535753. Dig Dis Sci. 1988. PMID: 3125026 Clinical Trial.
-
Treatment of nonsteroidal antiinflammatory drug-induced gastric ulcers with misoprostol. A double-blind multicenter study.Dig Dis Sci. 1992 Dec;37(12):1820-4. doi: 10.1007/BF01308074. Dig Dis Sci. 1992. PMID: 1473430 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical